Use of bisphosphonates in breast cancer metastatic to bone: Compliance with practice guidelines

Purpose We studied the effect of the dissemination of evidence-based guidelines on the prescription of bisphosphonates to women with breast cancer metastatic to bone. Methods To determine the number of patients eligible for bisphosphonate therapy as outlined by the Cancer Care Ontario Practice Guidelines Initiative, we conducted a single-institution audit of 1,682 consecutive ambulatory patients seen by five medical oncologists who specialise …